Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


12.06.2017

1 Clin Res Hepatol Gastroenterol
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
2 Hepatology
1 J Gen Virol
1 J Infect Dis
2 J Viral Hepat
1 Lancet Gastroenterol Hepatol
1 PLoS Med
1 Transfusion
2 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. MASCIA C, Lichtner M, Zuccala P, Vita S, et al
    Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Clin Res Hepatol Gastroenterol. 2017 May 31. pii: S2210-7401(17)30098.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. BERT F, Rindermann A, Abdelfattah MA, Stahmeyer JT, et al
    High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. ENOMOTO M, Murakami Y, Kawada N
    Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35638.
    PubMed     Text format    

  4. DE MARCO L, Pellicano R
    When to Search for Occult Infection After Eradication of Hepatitis C?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35601.
    PubMed     Text format    


    Hepatology

  5. CHOLANKERIL G, Wong RJ, Kim D, Ahmed A, et al
    Optimal Timing for Hepatitis C Antiviral Therapy in the Peri-Transplant Period?
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29300.
    PubMed     Text format    

  6. CHHATWAL J, Samur S, Bethea E, Chung RT, et al
    Response to Optimal Timing for Hepatitis C Antiviral Therapy in the Peri-Transplant Period?
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29299.
    PubMed     Text format    


    J Gen Virol

  7. HULLEGIE SJ, Arends JEA, Groothuismink ZMA, Pas SD, et al
    Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
    J Gen Virol. 2017 Jun 8. doi: 10.1099/jgv.0.000768.
    PubMed     Text format     Abstract available


    J Infect Dis

  8. UCHIYAMA S, Keller N, Schlaepfer E, Grube C, et al
    Interferon alpha-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.
    J Infect Dis. 2016;214:321-8.
    PubMed     Text format     Abstract available


    J Viral Hepat

  9. EL SHERIF O, Afhdal N, Curry M
    No one size fits all - shortening duration of therapy with direct acting antivirals for Hepatitis C genotype 1 infection.
    J Viral Hepat. 2017 Jun 5. doi: 10.1111/jvh.12734.
    PubMed     Text format     Abstract available

  10. JOHNSON K, Green PK, Ioannou GN
    Implications of HCV RNA level at week 4 of direct antiviral treatments for Hepatitis C.
    J Viral Hepat. 2017 Jun 5. doi: 10.1111/jvh.12731.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  11. BRUCHFELD A, Roth D, Martin P, Nelson DR, et al
    Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled t
    Lancet Gastroenterol Hepatol. 2017 May 30. pii: S2468-1253(17)30116.
    PubMed     Text format     Abstract available


    PLoS Med

  12. SCHUTZ E, Fischer A, Beck J, Harden M, et al
    Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    PLoS Med. 2017;14:e1002286.
    PubMed     Text format     Abstract available


    Transfusion

  13. VIEIRA PCM, Lamarao LM, Amaral CEM, Correa ASM, et al
    Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
    Transfusion. 2017 Jun 7. doi: 10.1111/trf.14146.
    PubMed     Text format     Abstract available


    Transplant Proc

  14. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Text format     Abstract available

  15. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Text format     Abstract available


    Transplantation

  16. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: